Publication Name	World Journal of Gastroenterology
Manuscript ID	63922
Country	Norway

Received	2021-02-05 15:14
Peer-Review Started	2021-02-05 15:19
To Make the First Decision
Return for Revision	2021-03-29 01:31
Revised	2021-04-03 12:36
Second Decision	2021-05-22 14:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-22 15:25
Articles in Press	2021-05-22 15:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-06-02 03:27
Publish the Manuscript Online	2021-06-08 10:51

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Frontier
Article Title	Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century
Manuscript Source	Invited Manuscript
All Author List	Magdy El-Salhy, Tanisa Patcharatrakul and Sutep Gonlachanvit
ORCID	Author(s) ORCID Number Magdy El-Salhy http://orcid.org/0000-0003-3398-3288 Tanisa Patcharatrakul http://orcid.org/0000-0003-1324-2394 Sutep Gonlachanvit http://orcid.org/0000-0002-8279-8778
Funding Agency and Grant Number	Funding Agency Grant Number Helse Fonna 40415
Corresponding Author	Magdy El-Salhy, BSc, MD, PhD, Chief Doctor, Professor, Department of Medicine, Stord Helse Fonna Hospital and University of Bergen, Tysevegen 64, Stord 5416, Norway. magdy.elsalhy@sklbb.no
Key Words	Butyric acid; Enteroendocrine cells; Etiology; Microbiota; Short-chain fatty acids; Superdonor; Therapy
Core Tip	Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. There is no effective treatment for IBS, but fecal microbiota transplantation (FMT) seems promising. Some randomized controlled trials (RCTs) have shown that FMT improved the symptoms and quality of life of IBS patients, but others have found no such effects. The discrepancies between the outcomes of these RCTs are due to the selection processes for the donor and treated patients, the dose of transplant used, and the route of administration. Further studies are needed to optimize the FMT conditions in IBS patients.
Publish Date	2021-06-08 10:51
Citation	El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943
URL	https://www.wjgnet.com/1007-9327/full/v27/i22/2921.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i22.2921

Full Article (PDF)	WJG-27-2921.pdf
Full Article (Word)	WJG-27-2921.docx
Manuscript File	63922_Auto_Edited-ZMG.docx
Answering Reviewers	63922-Answering reviewers.pdf
Audio Core Tip	63922-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63922-Conflict-of-interest statement.pdf
Copyright License Agreement	63922-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	63922-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	63922-Language certificate.pdf
Peer-review Report	63922-Peer-review(s).pdf
Scientific Misconduct Check	63922-Scientific misconduct check.pdf
Scientific Editor Work List	63922-Scientific editor work list.pdf